Seres Therapeutics, Inc. Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31)
Seres Therapeutics, Inc. (MCRB) reported Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) of 2.40% for the 12-month period ending 2015-12-31, per its 10-K filed 2017-03-16.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsRiskFreeInterestRate · last filed 2017-03-16
- Seres Therapeutics, Inc. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2015-03-31 was 1.83%.
- Seres Therapeutics, Inc. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2015 was 2.40%, a 10.60% increase from fiscal 2014.
- Seres Therapeutics, Inc. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2014 was 2.17%, a 32.19% decline from fiscal 2013.
- Seres Therapeutics, Inc. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2013 was 3.20%.
| Period end | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 3 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 6 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 9 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2015-12-31 | 2.40% 10-K · filed 2017-03-16 | |||
| 2015-09-30 | 2.40% 10-Q · filed 2016-11-10 | |||
| 2015-06-30 | 2.40% 10-Q · filed 2016-08-11 | |||
| 2015-03-31 | 1.83% 10-Q · filed 2016-05-16 | |||
| 2014-12-31 | 2.17% 10-K · filed 2017-03-16 | |||
| 2014-09-30 | 2.60% 10-Q · filed 2015-11-12 | |||
| 2014-06-30 | 2.56% 10-Q · filed 2015-08-10 | |||
| 2013-12-31 | 3.20% 10-K · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |